Alnylam Pharmaceuticals
ALNY
#622
Rank
NZ$56.88 B
Marketcap
$441.02
Share price
-1.16%
Change (1 day)
42.99%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company